MediGene AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other
companies in this sector in Germany:
Heidelberg Pharma Ag
sales of 3.67 million Euro [US$4.06 million]
(3.05 million Euro [US$3.37 million]
of which 100%
was Goods & Services), and
(4.17 million Euro [US$4.62 million]
MediGene AG reported sales of 7.75 million Euro (US$8.59 million)
December of 2018.
decrease of 24.7%
versus 2017, when the company's sales were 10.30 million Euro.
The sales level in 2018 was fairly close to the level five years ago: in 2013, MediGene AG had sales
of 7.59 million Euro.
Contributing to the drop in overall sales was the 42.8% decline
in Outlincencedproducts, from 2.79 million Euro to 1.60 million Euro.
However, these declines were partially offset by the increase in sales of
Immunotherapies (up 22.4% to 5.98 million Euro)